Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:0887 6924 "

Sökning: L773:0887 6924

Sortera/gruppera träfflistan
  • Andersson, Anna, et al. (författare)
  • Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status.
  • 2007
  • Ingår i: Leukemia. - : Nature Publishing Group. - 1476-5551 .- 0887-6924. ; 21:6, s. 1198-1203
  • Tidskriftsartikel (refereegranskat)abstract
    • Gene expression analyses were performed on 121 consecutive childhood leukemias (87 B-lineage acute lymphoblastic leukemias (ALLs), 11 T-cell ALLs and 23 acute myeloid leukemias (AMLs)), investigated during an 8-year period at a single center. The supervised learning algorithm k-nearest neighbor was utilized to build gene expression predictors that could classify the ALLs/AMLs according to clinically important subtypes with high accuracy. Validation experiments in an independent data set verified the high prediction accuracies of our classifiers. B-lineage ALLs with uncharacteristic cytogenetic aberrations or with a normal karyotype displayed heterogeneous gene expression profiles, resulting in low prediction accuracies. Minimal residual disease status (MRD) in T-cell ALLs with a high (40.1%) MRD at day 29 could be classified with 100% accuracy already at the time of diagnosis. In pediatric leukemias with uncharacteristic cytogenetic aberrations or with a normal karyotype, unsupervised analysis identified two novel subgroups: one consisting mainly of cases remaining in complete remission (CR) and one containing a few patients in CR and all but one of the patients who relapsed. This study of a consecutive series of childhood leukemias confirms and extends further previous reports demonstrating that global gene expression profiling provides a valuable tool for genetic and clinical classification of childhood leukemias.
  • Attarbaschi, A., et al. (författare)
  • Second malignant neoplasms after treatment of non-Hodgkin’s lymphoma—a retrospective multinational study of 189 children and adolescents
  • 2021
  • Ingår i: Leukemia. - 0887-6924. ; 35, s. 534-549
  • Tidskriftsartikel (refereegranskat)abstract
    • Data on the spectrum of second malignant neoplasms (SMNs) after primary childhood non-Hodgkin’s lymphoma (NHL) are scarce. One-hundred-and-eighty-nine NHL patients diagnosed in a 30 years period of 1980–2010 developing an SMN were retrieved from 19 members of the European Intergroup for Childhood NHL and/or the international Berlin-Frankfurt-Münster Study Group. Five subgroups of SMNs were identified: (1) myeloid neoplasms (n = 43; 23%), (2) lymphoid neoplasms (n = 51; 27%), (3) carcinomas (n = 48; 25%), (4) central nervous system (CNS) tumors (n = 19; 10%), and (5) “other” SMNs (n = 28; 15%). In 37 patients (20%) preexisting disorders were reported with 90% having any kind of cancer predisposition syndrome (CPS). For the 189 primary NHL patients, 5-year overall survival (OS) after diagnosis of an SMN was 56 ± 4%, being worst for patients with preexisting disorders at 28 ± 8%. Five-year OS rates were 38 ± 8%, 59 ± 7%, 79 ± 8%, 34 ± 12%, and 62 ± 11%, respectively, for patients with myeloid and lymphoid neoplasms, carcinomas, CNS tumors, and “other” SMNs (p < 0.0001). Patients with SMNs after childhood NHL having a reported CPS, mostly mismatch repair disorders, carried a very poor prognosis. Moreover, although outcome was favorable in some subtypes of SMNs after childhood NHL (carcinomas, lymphoid neoplasms), other SMNs such as myeloid neoplasms and CNS tumors had a dismal prognosis. © 2020, The Author(s), under exclusive licence to Springer Nature Limited.
  • Baliakas, Panagiotis, et al. (författare)
  • Recurrent mutations refine prognosis in chronic lymphocytic leukemia
  • 2015
  • Ingår i: Leukemia. - : Nature Publishing Group. - 0887-6924 .- 1476-5551. ; 29, s. 329-336
  • Tidskriftsartikel (refereegranskat)abstract
    • Through the European Research Initiative on chronic lymphocytic leukemia (CLL) (ERIC), we screened 3490 patients with CLL for mutations within the NOTCH1 (n=3334), SF3B1 (n=2322), TP53 (n=2309), MYD88 (n=1080) and BIRC3 (n=919) genes, mainly at diagnosis (75%) and before treatment (>90%). BIRC3 mutations (2.5%) were associated with unmutated IGHV genes (U-CLL), del(11q) and trisomy 12, whereas MYD88 mutations (2.2%) were exclusively found among M-CLL. NOTCH1, SF3B1 and TP53 exhibited variable frequencies and were mostly enriched within clinically aggressive cases. Interestingly, as the timespan between diagnosis and mutational screening increased, so too did the incidence of SF3B1 mutations; no such increase was observed for NOTCH1 mutations. Regarding the clinical impact, NOTCH1 mutations, SF3B1 mutations and TP53 aberrations (deletion/mutation, TP53ab) correlated with shorter time-to-first-treatment (P<0.0001) in 889 treatment-naive Binet stage A cases. In multivariate analysis (n=774), SF3B1 mutations and TP53ab along with del(11q) and U-CLL, but not NOTCH1 mutations, retained independent significance. Importantly, TP53ab and SF3B1 mutations had an adverse impact even in U-CLL. In conclusion, we support the clinical relevance of novel recurrent mutations in CLL, highlighting the adverse impact of SF3B1 and TP53 mutations, even independent of IGHV mutational status, thus underscoring the need for urgent standardization/harmonization of the detection methods.
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (233)
forskningsöversikt (7)
konferensbidrag (5)
annan publikation (1)
Typ av innehåll
refereegranskat (200)
övrigt vetenskapligt (46)
Rosenquist, R. (39)
Stamatopoulos, K (29)
Rosenquist, Richard (25)
Forestier, E (25)
Juliusson, G (20)
Ghia, P (20)
visa fler...
Davi, F (18)
Schmiegelow, K (18)
Belessi, C (17)
Hoglund, M (17)
Mansouri, L. (15)
Johansson, B (15)
Heyman, M (15)
Barbany, G (15)
Porwit-MacDonald, A (14)
Johansson, Bertil (13)
Juliusson, Gunnar (13)
Soderhall, S (13)
Stenke, L (13)
Forestier, Erik (12)
Nordgren, A (12)
Jonsson, O. G. (12)
Lundin, J (12)
Höglund, Martin (12)
Osterborg, A (11)
Abrahamsson, J (11)
Anagnostopoulos, A (11)
Vettenranta, K (11)
Smedby, K E (11)
Richter, J (11)
Lehmann, S (10)
Mansouri, Larry (10)
Sundstrom, C (10)
Gustafsson, G (10)
Hadzidimitriou, A (10)
Pospisilova, S (10)
Lonnerholm, G (10)
Olsson-Stromberg, U (10)
Markevarn, B (10)
Hjorth-Hansen, H (10)
Nordenskjold, M (9)
Sutton, Lesley-Ann (9)
Sutton, LA (9)
Wahlin, A (9)
Smedby, KE (9)
Vaitkeviciene, G (9)
Fioretos, T. (9)
Behrendtz, M (9)
Höglund, M (9)
Griskevicius, L (9)
visa färre...
Karolinska Institutet (115)
Uppsala universitet (93)
Lunds universitet (47)
Umeå universitet (35)
Linköpings universitet (26)
Göteborgs universitet (19)
visa fler...
Örebro universitet (4)
Kungliga Tekniska Högskolan (3)
Karlstads universitet (1)
visa färre...
Engelska (244)
Odefinierat språk (2)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (126)
Naturvetenskap (2)


Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy